Annual report pursuant to Section 13 and 15(d)

Stockholders Equity (Details) - Schedule of summary of options granted to purchase

v3.23.1
Stockholders Equity (Details) - Schedule of summary of options granted to purchase - Stock Option [Member] - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Stockholders Equity (Details) - Schedule of summary of options granted to purchase [Line Items]    
Number of Options, Outstanding at the beginning of period 4,084,549 3,569,766
Weighted average exercise price, Outstanding at the beginning of period (in Dollars per share) $ 3.95 $ 3.12
Aggregate intrinsic value, Outstanding at the beginning of period (in Dollars) $ 671 $ 12,338
Number of Options, Granted 1,814,000 985,530
Weighted average exercise price, Granted (in Dollars per share) $ 1.14 $ 7.02
Number of Options, Forfeited (1,129,108) (386,508)
Weighted average exercise price, Forfeited (in Dollars per share) $ 3.74 $ 4.6
Number of Options, Exercised (84,239)
Weighted average exercise price, Exercised (in Dollars per share) $ 1.55
Number of Options, Outstanding at the end of period 4,769,441 4,084,549
Weighted average exercise price, Outstanding at the end of period (in Dollars per share) $ 2.93 $ 3.95
Aggregate intrinsic value, Outstanding at the end of period (in Dollars) $ 40 $ 671
Number of Options, Vested at end of period   2,486,381
Exercisable at the end of period 2,688,238  
Number of Options, Weighted average remaining contractual life – years 7 years 6 years 9 months 25 days